Advanced Search

 

Study ID Status Title Patient Level Data
FLD40001 Completed A randomised double-blind, active-controlled study to compare the systemic effects of fluticasone propionate ointment 0.005%, mometasone furoate ointment 0.1% and placebo ointment applied under occlusion for 5 days in healthy volunteers
FLD40002 Completed A Comparative evaluation of the atrophogenic potential of fluticasone propionate ointment 0.005%, mometasone furoate ointment 0.1% and hydrocortisone ointment 1% in healthy volunteers.
FLIC06 Completed Inhaled Fluticasone Propionate in Asthmatic children. A multicentre, double-blind, double dummy, parallel group study to compare the efficacy and tolerability of inhaled fluticasone propionate 50mcg bid via metered dose inhaler (MDI) with sodium cromoglycate (DSCG) 10mg qds via metered dose inha ...
FLIC09 Completed Nebulised Fluticasone propionate in an upper respiratory tract inflammatory disorder (rhinopharyngitis): a multicentre, randomised, blinded, parallel group study of the efficacy and safety of nebulised fluticasone propionate 0.5mg daily compared with nebulised beclomethasone dipropionate 0.8mg d ...
FLIC12 Completed A multicentre, blinded, parallel group, randomized study to compare the efficacy and tolerability of nebulised Fluticasone propionate 0.25mg administered twice daily versus nebulised Budesonide 0.5mg administered twice daily in children with mild asthma.
FLIC15 Completed A multicenter, randomised, double-blind, parallel group study of the efficacy of fluticasone propionate (FP) diskus 100mcg/bid or 500mcg/bid to induce variations of eosinophils and of Eosinophil Cationic Protein (ECP) in serum and in sputum and to induce variations of exhaling nitric oxide (NO) ...
FLIC16 Completed A multicentre, randomised, double-blinded, parallel-group comparison of the efficacy and tolerability of fluticasone propionate 100mcg bid with nedocromil MDI 4mg bid in mild-moderate asthmatic children
FLIP01 Completed Inhaled Fluticasone Propionate for the Treatment of Moderately Severe Asthma in Patients Not Already Taking Inhaled Steroids. A Dose-Ranging Study and Comparison with Inhaled Beclomethasone Dipropionate.
FLIT 72 Completed A Multicentre, Randomised, Double-Blind, Parallel Group, Six-Week Study To Compare The Efficacy and Safety of Fluticasone Propionate 500?g Daily via the Pressurised Inhaler and via the Diskhaler™ Inhaler with Beclomethasone Dipropionate 1000?g Daily via the Pressurised Inhaler in Patients with M ...
FLIT 72_1 Completed A multicentre, randomised, double-blind, parallel group, six-week study to compare the efficacy and safety of fluticasone propionate 500mcg daily via the metered dose inhaler and via the Diskhaler inhaler with beclomethasone dipropionate 1000mcg daily via the metered dose inhaler followed by a 4 ...
FLIT94/004V2 Completed A multicentre, randomised, double-blind, parallel-group study to compare the efficacy and tolerability of fluticasone propionate 500 µg bd administered by pressurised inhaler propelled by a mixture of propellants 11/12 or by an alternative propellant GR106642X for a period of three months in adu ...
FLIT94/030 Completed A multicentre, randomised, double-blind, parallel-group study to compare the efficacy and tolerability of fluticasone propionate 500 mcg bd administered by pressurised inhaler propelled by a mixture of propellants 11/12 or by an…
FLIT98 Completed Inhaled fluticasone propionate in an acute exacerbation of chronic obstructive pulmonary disease: a multi-centre, randomised, double-blind, parallel group study of the efficacy and safety of inhaled fluticasone propionate 2000 µg daily compared with placebo in chronic obstructive pulmonary dise ...
FLIT99 Completed A double-blind, randomised, parallel group, placebo-controlled study of inhaled fluticasone propionate delivered via the Babyhaler™ in the prevention of post-bronchiolitic respiratory symptoms in infants.
FLIT-CN02 Completed An open, multicenter, randomized, parallel group study to compare the efficacy and safety of local manufactured fluticasone propionate with imported fluticasone propionate in the treatment of patients with moderate to severe asthma.
FLN202 Completed A double-blind, randomized, placebo-controlled dose-ranging study of the efficacy and safety of twice-daily intranasal administration of aqueous fluticasone propionate in adult patients with seasonal allergic rhinitis.
FLN-203 Completed Title: A double-blind, randomized, placebo-controlled study of the efficacy and safety of once- versus twice-daily intranasal administration of aqueous fluticasone proprionate for two weeks in adult patients with seasonal allergic rhinitis
FLN-204 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of once- versus twice-daily intranasal administration of aqueous fluticasone propionate for four weeks in adult patients with seasonal allergic rhinitis
FLN-230 Completed A double-blind, double-dummy, randomized, parallel group comparison of the efficacy of intranasal and oral fluticasone propionate in patients with seasonal allergic rhinitis.
FLN-260 Completed A double-blind, placebo-controlled, dose-tolerance study to assess the effects of fluticasone propionate aqueous nasal spray versus oral prednisone on the HPA axis
FLN-270 Completed A double-blind, randomized, placebo-controlled, parallel group study comparing fluticasone propionate aqueous nasal spray 200µg QD manufactured with two different procedures in patients with seasonal allergic rhinitis
FLN-305 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once- versus twice-daily versus placebo for two weeks in adolescent patients with seasonal allergic rhinitis
FLN-306 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once- versus twice-daily versus aqueous beclomethasone dipropionate versus placebo for four weeks in adult and adolescent patients with seasonal allergic rhinitis.
FLN-320 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once daily versus placebo for two weeks in pediatric patients with seasonal allergic rhinitis
FLN-350 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of two doses of fluticasone propionate aqueous nasal spray given twice daily versus placebo for four weeks in patients with perennial nonallergic rhinitis

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.